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Background: The transcription factor 7-like 2 (TCF7L2) gene is the most significant genetic risk factor for type 2
diabetes (T2D). Association analyses were performed on participants (n = 751, aged between 30 and 64) in the ISOR
population-based study in the city of Oran. Dietary intakes were estimated using a weekly food frequency
questionnaire.
Results: The T allele of the rs7903146 single nucleotide polymorphism (SNP) was associated with lower body
weight (p = 0.02), lower BMI (p = 0.009), lower waist circumference (p = 0.01) and a lower waist-to-hip ratio (p = 0.02).
The T allele was associated with a significantly higher risk of T2D (odds ratio (OR) (95% confidence interval) = 1.55
(1.09–2.20), p = 0.01) and this association was independent of BMI. When considering the T2D risk, there were
nominal interactions between the rs7903146 SNP and dessert (p = 0.05) and milk intakes (p = 0.01). The T2D risk was
greater in T allele carriers with high dessert and milk intakes (OR = 2.61 (1.51-4.52), p = 0.0006, and 2.46 (1.47-4.12),
p = 0.0006, respectively). In subjects with a high dessert intake, the T allele was also associated with higher fasting
plasma glucose concentrations (4.89 ± 0.46 mmol/L in TT subjects, 4.72 ± 0.48 mmol/L in CT subjects and 4.78 ±
0.51 mmol/L in CC subjects; p = 0.03).
Conclusions: The T allele of the rs7903146 SNP is associated with a significantly higher risk of T2D in an Algerian
population. This association was further strengthened by a high dessert intake, suggesting that gene-diet
interactions increase the T2D risk.
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Type 2 diabetes mellitus (T2D) is characterized by hyper-
glycemia as a result of impaired insulin secretion, insulin
resistance in peripheral tissues and/or increased glucose
output by the liver [1]. As observed worldwide, the preva-
lence of diabetes is increasing in Algeria. Indeed, the
prevalence has almost doubled over the last 20 years (from
6.9% in 1990 [2] to 13% in 2007 [3]). The increase might
be due to the rapid changes in lifestyle recently observed
in this Northern African country.* Correspondence: aline.meirhaeghe@pasteur-lille.fr
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article, unless otherwise stated.Setting aside the rare monogenic forms of the disease
[1], T2D arises from interactions between the patient’s
genetic background and his/her environment. An associ-
ation between rs7903146 of the transcription factor 7-
like 2 (TCF7L2) gene and the T2D risk was identified for
the first time in a study of Icelandic, American and Danish
subjects [4], and has since been consistently replicated in
various European and non-European populations (includ-
ing Indian and Japanese populations) [5-9]. In Arab popu-
lations, strong associations have been observed in
Tunisian [10,11], Moroccan, Palestinian [12], Iranian [13]
and Lebanese [14] studies.
To the best of our knowledge, there are no published
data on the impact of the TCF7L2 rs7903146 SNP ind Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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associations between this SNP, the T2D risk and quantita-
tive metabolic phenotypes in a sample of the Algerian
population (the ISOR (Insulino-résistance à Oran) study).
We also looked at whether or not dietary intakes could
modulate these putative associations.
Methods
Subjects
The ISOR population-based, cross-sectional study was
performed between 2007 and 2009. It investigated a rep-
resentative sample of 787 subjects (378 men and 409
women, aged between 30 and 64) recruited from within
the city of Oran in western Algeria. Subjects were se-
lected at random from social security registers. A ques-
tionnaire on lifestyle (physical activity, tobacco use and
alcohol intake), personal and family medical histories,
current medication and socio-economic and educational
levels was completed during a face-to-face interview.
The study has been described in detail elsewhere [15].
Food intake was assessed with a weekly food frequency
questionnaire: consumption of butter, peanuts, desserts
(i.e. sweet dishes, including pastries, custards, pudding,
sorbets, etc.), fruits, dried fruits, olive oil, other oils,
milk, vegetables, dried vegetables, eggs, bread, potatoes,
pasta, fish, chicken and meat products during the week
before administration of the questionnaire was noted and
then expressed as the frequency of intake (per day or per
week). After calculating the median value for the intake of
each food type, we defined two groups: non-/low con-
sumers (i.e. those whose intake was below the median
value) and moderate/high consumers (i.e. those whose
intake was greater than or equal to the median value).
The homeostasis model assessment insulin resistance
(HOMA-IR) index was calculated as (fasting plasma glu-
cose (mmol/L) × fasting plasma insulin (mIU/L)/22.5) [16].
The homeostasis model assessment of beta-cell function
(HOMA-B) was calculated as (20 × fasting plasma insu-
lin (mIU/L)/fasting plasma glucose (mmol/L)-3.5) [17].
Of the 751 genotyped subjects in the ISOR study, 76
had T2D (defined according to the American Diabetes
Association (ADA) criteria, i.e. fasting plasma glucose ≥
7.0 mmol/L and/or treatment for diabetes, including
diets and/or oral antidiabetic drugs and/or insulin for
the achievement of glycemic control [18,19]) and 644
did not. Seventeen of the 76 diabetics had not been
diagnosed prior to the ISOR study.Ethics
The study’s objectives and procedures were approved by
the independent ethics committee (Agence Thématique
de Recherche en Sciences de la Santé, Oran, Algeria).
The datasets were anonymized and the subjects’ names,initials or hospital identification numbers were not
used. All subjects gave their written, informed consent
to participation.Genotyping
Genomic DNA was extracted from white blood cells by
using a Stratagene® kit (Agilent Technologies, Les Ulis,
France), according to the manufacturer’s protocol. The
TCF7L2 rs7903146 SNP was genotyped using KASPar
technology (a competitive allele-specific polymerase
chain reaction incorporating a fluorescent resonance en-
ergy transfer quencher cassette (KBioscience, Hoddesdon,
UK). The KASPar assay was designed using Primer Picker
software (KBioscience). Genotyping assays was carried out
with a Hydrocycler (Applied Biosystems, Foster City, CA)
in a final volume of 2 μl containing 4× Reaction Mix
(KBioscience), 120 nM of each allele-specific primer, 300
nM of common primer, 1.5 μl of Master Mix (KBioscience)
and 5 ng of genomic DNA. The following thermal cyc-
ling profile was used: 15 min at 94°C; 20 cycles of 10 s
at 94°C, 5 s at 57°C and 10 s at 72°C; and 18 cycles of
10 s at 94°C, 20 s at 57°C and 40 s at 72°C. The specific
probe sequence was [AGCACTTTTTAGATA[C/T]
TATATAATTTAATTG]. The genotyping success rate
was 96%. Appropriate negative control samples were used,
including two non-DNA controls per 96-well plate.
Around 9% of the participants in the ISOR study were
genotyped twice, with a concordance rate of 100%.Statistical analyses
Statistical analyses were performed with SAS software
(version 9.1, SAS Institute Inc., Cary NC). Hardy-
Weinberg equilibrium was tested using a chi-squared
test with one degree of freedom. Allele frequencies
and genotype distributions in T2D and control groups
were compared using Pearson’s chi-squared test. Inter-
group comparisons of means were performed with a
general linear model (GLM). In order to obtain normal
data distributions, fasting glucose, insulin and triglyceride
concentrations and HOMA-IR and HOMA-B indices
were log-transformed. Interaction with dietary intakes was
tested by adding an SNP × food intake interaction term to
the GLM model. Odds ratios (ORs) were calculated in
multivariate logistic regression analyses. The adjustment
variables were age, gender, smoking status and level of
physical activity (plus BMI for biochemical and clinical
variables).
Bonferroni correction for multiple testing was used to
adjust gene-diet interaction analyses and the threshold
for statistical significance was set to p ≤ 0.0029 (i.e. 0.05
divided by the seventeen food items). For other tests, the
threshold for statistical significance was set to p ≤ 0.05.
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Characteristics of the study subjects
The clinical characteristics of the study subjects’ are sum-
marized in Table 1. The prevalence of T2D in the ISOR
study was 10.5%. The T2D subjects were older than non-
T2D subjects (p = 9.4 × 10−15). The T2D and non-T2D
subjects had similar mean total cholesterol, high-density
lipoprotein (HDL)-cholesterol and low-density lipoprotein
(LDL)-cholesterol values. However, T2D subjects had
significantly higher anthropometric parameters, fasting
glucose (p = 5.71 × 10−176), fasting insulin (p = 0.002),
HOMA-IR (p = 4.5 × 10−25), HOMA-B (p = 6.8 × 10−37),
triglyceride (p = 4.4 × 10−11) concentrations, systolic blood
pressure (SBP) values (p = 6.3 × 10−8) and diastolic blood
pressure (DBP) values (p = 4.5 × 10−5) than non-T2D
subjects.
Associations with T2D risk and quantitative
metabolic traits
The frequencies of the CC, CT, and TT genotypes of the
TCF7L2 rs7903146 SNP in the ISOR study (n = 751)
were 0.34, 0.46 and 0.20, respectively (Table 2). This
genotype distribution conformed to Hardy-Weinberg
equilibrium (p = 0.07). The frequency of the minor T
allele was 0.43. The T2D subjects and non-T2D subjects
differed significantly in terms of the TCF7L2 rs7903146
genotype distribution (p = 0.04) and allele distribution
(p = 0.02) (Table 2). The T allele was more frequent inTable 1 Clinical characteristics of the genotyped subjects




(n = 644) (n = 76)
Age (years) 42.8 ± 9.6 52.0 ± 9.5 9.4 × 10−15
Weight (kg) 70.6 ± 14.6 75.6 ± 13.9 0.005
BMI (kg/m2) 25.8 ± 5.1 27.9 ± 5.2 0.001
Waist (cm) 86.4 ± 12.2 95.6 ± 10.9 5.8 × 10−10
Hip (cm) 101.7 ± 9.7 102.5 ± 11.0 0.53
Waist-to-hip ratio 0.85 ± 0.08 0.94 ± 0.11 9.0 × 10−17
Fasting glucose (mmol/L) 4.78 ± 0.49 9.58 ± 3.02 5.71 × 10−176
Fasting insulin (μIU/mL) 7.94 ± 5.67 11.34 ± 10.70 0.002
HOMA-IR 1.7 ± 1.2 4.7 ± 5.2 4.5 × 10−25
HOMA-B 144.7 ± 130.3 51.8 ± 55.9 6.8 × 10−37
Triglycerides (mmol/L) 1.11 ± 0.47 1.58 ± 0.70 4.4 × 10−11
Total cholesterol (mmol/L) 4.44 ± 0.90 4.54 ± 1.03 0.33
HDL-cholesterol (mmol/L) 1.26 ± 0.31 1.21 ± 0.30 0.17
LDL-cholesterol (mmol/L) 2.68 ± 0.85 2.67 ± 1.03 0.92
SBP (mmHg) 122.1 ± 17.2 133.6 ± 22.2 6.3 × 10−8
DBP (mmHg) 76.2 ± 9.9 81.1 ± 9.2 4.5 × 10−5
Data are expressed as the mean ± standard deviation.T2D subjects than in non-T2D subjects and was signifi-
cantly associated with a higher risk of T2D (OR (95%
confidence interval (CI)) = 1.55 (1.09–2.20); p = 0.01 in an
additive model). Further adjustment for BMI did not
substantially alter this association (OR = 1.62 (1.13–2.31),
p = 0.008).
We also searched for associations between the
rs7903146 SNP and anthropometric variables (BMI, body
weight, waist circumference and waist-to-hip ratio), bio-
chemical variables (fasting glucose, fasting insulin and
lipid concentrations, HOMA-IR and HOMA-B) and clin-
ical variables (SBP and DBP) in non-T2D subjects from
the ISOR study (n = 644) (Table 3). The T allele of the
rs7903146 SNP was significantly associated with lower
body weight (p = 0.02), BMI (p = 0.009), waist (p = 0.01)
and waist-to-hip ratio (p = 0.02). HOMA-B and DBP
values were respectively lower and higher in T allele
carriers than in C allele carriers, although these differences
were not statistically significant (p = 0.08 for both).
Gene-diet interactions
Next, as an exploratory approach, we looked at whether
the subjects’ dietary intakes might influence the associa-
tions described above. In the ISOR study, we observed
high intakes of desserts (consumed at least once a day
by 67.6% of the subjects), milk (consumed at least twice
a day by 51.3% of the subjects), bread (consumed at least
twice a day by 92.9% of the subjects) and vegetable oil
(consumed at least twice a day by 66.7% of the subjects)
(Figure 1) and very low intakes of olive oil and fish.
For each food type, the subjects were dichotomized
into non-/low consumers or moderate/high consumers
as a function of the median dietary intake value. When
considering the T2D risk, we detected nominal interac-
tions between the TCF7L2 rs7903146 SNP on one hand
and dessert and milk intakes (p = 0.05 and p = 0.01, re-
spectively) on the other (Table 4). In subjects with a high
dessert intake (≥ once a day) or milk intake (≥ twice a
day), the rs7903146 SNP was strongly associated with T2D
(OR = 2.61 (1.51-4.52), p = 0.0006 for desserts; OR = 2.46
(1.47-4.12), p = 0.0006 for milk). Conversely, an elevated
risk was not observed in non-/low consumers of desserts
and milk. Despite the absence of significant interactions
with other types of food (relative to the population as a
whole; OR = 1.62 for T allele carriers), the T2D risk was
even higher in non-/low consumers of peanuts, fruits,
dried vegetables, pasta and chicken and in moderate/
high consumers of butter, olive oil, other oils and bread
(ORs > 2) (Table 4).
Lastly, we looked whether the impact of the TCF7L2
rs7903146 SNP on anthropometric and glucose-related
variables could be modified by dessert and milk intakes
in non-T2D subjects (n = 644). No interactions could be
observed for milk intake (data not shown). In contrast,
Table 2 Association between the TCF7L2 rs7903146 SNP and the T2D risk in the ISOR study
ISOR Non-T2D subjects T2D subjects Additive model
(T vs C allele)
Dominant model
(CT + TT vs CC)
Recessive model
(TT vs CC + CT)
n (frequency) n (frequency) n (frequency) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
n 720 644 76
CC 244 (0.39) 228 (0.35) 16 (0.21)
CT 328 (0.45) 287 (0.45) 41 (0.54) 0.04 1.55 (1.09-2.20)* 0.01* 2.26 (1.24-4.13)* 0.008* 1.46 (0.80-2.64)* 0.22*
TT 148 (0.20) 129 (0.20) 19 (0.25) 1.62 (1.13-2.31)† 0.008† 2.38 (1.30-4.36)† 0.005† 1.54 (0.85-2.82)† 0.16†
C allele 818 (0.57) 743 (0.58) 73 (0.48) 0.02
T allele 624 (0.43) 545 (0.42) 79 (52)
The odds ratios (OR) (95% confidence interval (CI)) and the p values were obtained from logistic regression analyses using additive, dominant or recessive models,
adjusted for *age, gender, physical activity and smoking status or †age, gender, physical activity, smoking status and BMI.
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and rs7903146 when considering plasma fasting glucose
concentrations (p = 0.02) (Table 5). The T allele was
associated with higher fasting plasma glucose concentra-
tions (p = 0.03)only in subjects consuming at least one
dessert a day.
Discussion
Genetic variants in TCF7L2 are strongly associated with
the T2D risk in many populations [7]. In the present
study, we replicated the association between the TCF7L2
rs7903146 polymorphism and the T2D risk in a popula-
tion sample from the city of Oran (Algeria).
In the literature, the minor allele frequency of the
rs7903146 SNP ranges from 0.30 in Europeans to 0.032Table 3 Association between the TCF7L2 rs7903146 SNP and
non-T2D subjects in the ISOR study
Parameter CC
(n = 228)
Weight (kg) 72.1 ± 14.0
BMI (kg/m2) 26.4 ± 5.0
Waist (cm) 88.1 ± 12.2
Hip (cm) 102.5 ± 9.7
Waist-to-hip ratio 0.86 ± 0.09
Fasting glucose (mmol/L) 4.80 ± 0.50
Fasting insulin (μIU/mL) 8.58 ± 6.67
HOMA-IR 1.8 ± 1.4
HOMA-B 160.9 ± 172.5
Triglycerides (mmol/L) 1.14 ± 0.49
Total cholesterol (mmol/L) 4.43 ± 0.93
HDL-cholesterol (mmol/L) 1.25 ± 0.32
LDL-cholesterol (mmol/L) 2.67 ± 0.86
SBP (mmHg) 122.0 ± 16.2
DBP (mmHg) 75.9 ± 9.1
Data are presented as the mean ± standard deviation.
p values were adjusted for age, gender, smoking status and physical activity (plus B
indicated in bold type.in Asians [20] and 0.42 in Tunisians [10]. The latter
value is very close to the frequency observed here (0.43)
for an Algerian population.
Genome-wide association studies in populations of
European descent have shown that TCF7L2 is the T2D-
predisposing gene with the largest effect reported to date
[5,7]. A meta-analysis of 35 studies confirmed the associ-
ation between the rs7903146 SNP and T2D in a variety of
populations, with an overall, homogeneous OR (95% CI)
of 1.97 (1.79-2.16) [20]. Although Algerian populations are
generally more genetically diverse than European, Asian
or indigenous American populations, our results extend
the list of populations in which the rs7903146 SNP is asso-
ciated with T2D risk. Indeed, Northern Africa’s strategic
location at the crossroads between Europe, the Middleanthropometric, biochemical and clinical parameters in
CT TT p
(n = 287) (n = 129)
70.7 ± 15.2 67.7 ± 14.1 0.02
25.7 ± 5.1 24.9 ± 5.1 0.009
86.1 ± 12.2 84.3 ± 11.9 0.01
101.6 ± 9.6 100.6 ± 9.9 0.06
0.85 ± 0.08 0.84 ± 0.08 0.02
4.75 ± 0.50 4.82 ± 0.49 0.34
7.91 ± 5.40 6.88 ± 4.00 0.25
1.7 ± 1.2 1.5 ± 0.9 0.36
144.7 ± 112.1 114.4 ± 72.9 0.08
1.14 ± 0.45 1.02 ± 0.47 0.24
4.46 ± 0.89 4.38 ± 0.89 0.95
1.24 ± 0.29 1.30 ± 0.34 0.53
2.71 ± 0.85 2.64 ± 0.84 0.84
122.5 ± 18.1 121.5 ± 16.9 0.23
76.5 ± 10.8 76.2 ± 9.5 0.08
MI for biochemical and clinical variables). Statistically significant p values are
Figure 1 Weekly intakes of each food type in the ISOR study. Dietary intakes were estimated with a weekly food frequency questionnaire.
The consumption of various food types during the week preceding the administration of the questionnaire was noted and then expressed as the
frequency of consumption (per day or per week). For each food type, the number of subjects corresponding to each weekly frequency is shown.
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display various combinations of five distinct ancestries.
Henn et al. have observed an East-to-West increase in the
likelihood of autochthonous Maghrebi ancestry across









Butter 0.10 237 37 1.14 (0.66-1
Peanuts 0.62 386 47 1.76 (1.10-2
Desserts 0.05 207 42 1.13 (0.68-1
Fruits 0.31 254 25 2.04 (1.11-3
Dried fruits 0.54 379 42 1.41 (0.87-2
Vegetables 0.12 269 37 1.16 (0.69-1
Dried vegetables 0.61 292 42 1.72 (1.07-2
Olive oil 0.50 417 49 1.41 (0.92-2
Other oils 0.10 202 29 1.03 (0.56-1
Milk 0.01 311 37 1.05 (0.62-1
Eggs 0.93 214 28 1.59 (0.91-2
Bread 0.50 316 33 1.40 (0.82-2
Potatoes 0.69 278 36 1.67 (0.99-2
Pasta 0.36 243 31 1.88 (1.06-3
Fish 0.76 244 25 1.33 (0.71-2
Chicken 0.54 192 25 1.89 (1.00-3
Meat 0.94 219 27 1.61 (0.88-2
p values were adjusted for age, gender, smoking status and BMI. Statistically significhere, the rs7903146 polymorphism was associated with a
62% increase in the T2D risk. Therefore, TCF7L2 is a
population-independent susceptibility locus for T2D in
Europeans [5], African-Americans [22], Arabs (for a review,
see [23]) and Algerians (the present work).T2D risk, as a function of food type intakes





OR (95% CI) p
.98) 0.63 404 39 1.98 (1.23-3.20) 0.005
.82) 0.02 255 29 1.41 (0.81-2.43) 0.22
.86) 0.63 434 34 2.61 (1.51-4.52) 0.0006
.76) 0.02 387 51 1.40 (0.90-2.16) 0.01
.29) 0.16 262 34 1.70 (0.98-2.95) 0.06
.94) 0.57 372 39 2.11 (1.28-3.50) 0.0036
.77) 0.03 348 34 1.50 (0.88-2.55) 0.14
.16) 0.12 224 27 1.98 (1.05-3.75) 0.03
.89) 0.93 439 47 1.98 (1.27-3.07) 0.003
.77) 0.86 330 39 2.46 (1.47-4.12) 0.0006
.78) 0.11 427 48 1.64 (1.04-2.60) 0.03
.40) 0.22 325 43 1.92 (1.18-3.12) 0.009
.81) 0.06 363 40 1.47 (0.91-2.38) 0.11
.33) 0.03 398 45 1.44 (0.91-2.27) 0.12
.48) 0.37 397 51 1.68 (1.09-2.58) 0.02
.56) 0.05 428 46 1.44 (0.91-2.27) 0.12
.95) 0.12 422 49 1.65 (1.06-2.56) 0.03
ant p values are indicated in bold type.
Table 5 Impact of the rs7903146 SNP on anthropometric and glucose-related variables in non-T2D subjects, as a
function of dessert intake
Non-/low consumers Consumers/high consumers
Parameter Interaction p CC CT TT p CC CT TT p
N 79 87 41 147 199 88
Weight (kg) 0.41 72.5 ± 14.0 69.6 ± 15.5 66.5 ± 12.5 0.04 71.8 ± 14.0 71.2 ± 15.0 68.3 ± 14.8 0.18
BMI (kg/m2) 0.83 26.5 ± 4.9 26.0 ± 5.3 24.7 ± 4.5 0.08 26.3 ± 5.1 25.6 ± 5.0 25.0 ± 5.3 0.06
Waist (cm) 0.60 89.3 ± 12.6 86.0 ± 12.0 84.5 ± 11.8 0.06 87.5 ± 11.9 86.1 ± 12.3 84.2 ± 12.0 0.10
Hip (cm) 0.87 102.0 ± 10.2 101.5 ± 9.0 99.9 ± 7.9 0.22 102.8 ± 9.4 101.6 ± 9.9 101.0 ± 10.8 0.13
Waist-to-hip ratio 0.24 0.88 ± 0.09 0.85 ± 0.08 0.84 ± 0.08 0.07 0.85 ± 0.08 0.85 ± 0.08 0.83 ± 0.08 0.28
Fasting glucose (mmol/L) 0.02 4.84 ± 0.49 4.81 ± 0.54 4.66 ± 0.53 0.29 4.78 ± 0.51 4.72 ± 0.48 4.89 ± 0.46 0.03
Fasting insulin (μIU/mL) 0.24 9.27 ± 7.69 8.83 ± 6.94 6.40 ± 3.83 0.20 8.21 ± 6.05 7.51 ± 4.54 7.10 ± 4.08 0.99
HOMA-IR 0.12 2.0 ± 1.5 1.9 ± 1.7 1.4 ± 0.9 0.16 1.8 ± 1.3 1.6 ± 1.0 1.6 ± 1.0 0.67
HOMA-B 0.41 167.5 ± 189.6 150.9 ± 125.5 120.7 ± 72.9 0.77 157.3 ± 163.1 141.9 ± 106.0 111.6 ± 72.8 0.08
p values were adjusted for age, gender, smoking status and physical activity (plus BMI for glucose and insulin-related variables). Statistically significant p values
are indicated in bold type.
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rs7903146 SNP on T2D, we also searched for associations
with quantitative metabolic risk factors. The literature data
show that the rs7903146 SNP is associated with fasting
glucose concentrations, fasting insulin concentrations and
the HOMA-B index [24,25]. In the ISOR population, T
allele carriers tended to have lower HOMA-B than C allele
carriers (p = 0.08) and thus lower insulin secretion, which
may explain the association with T2D.
In the present study, the T risk allele was also associated
with a lower body weight, BMI, abdominal circumference
and waist-to-hip ratio. This observation has been made in
a number of population samples [4,24,26,27] but contrasts
with another study in which the risk allele was associated
with higher BMI [28]. Interestingly, TCF7L2 is expressed
in adipose tissue and is involved in Wnt-dependent regu-
lation of adipogenesis [29]. Moreover, an investigation of
the association of TCF7L2 variants with body fat compos-
ition and ectopic lipid storage after a nine-month lifestyle
intervention (weight loss) showed that the TCF7L2
rs7903146 SNP had a negative impact on changes in BMI,
non-visceral fat and visceral fat [30].
We also explored the possible influence of diet on T2D
risk, as dietary factors have a key role in the development
of the condition. Indeed, European and Northern African
diets differ significantly in terms of their qualitative com-
position [31]. The most striking differences usually con-
cern the proportion of fat in the energy intake. European
populations have a high fat intake, whereas Northern
African populations have a high carbohydrate intake [31].
The Diabetes Prevention Program [26] and the Finnish Dia-
betes Prevention Study [32] provided the first indications
that environmental or lifestyle factors might influence the
genetic effect of TCF7L2 polymorphisms. Moreover,
other studies have reported interactions between TCF7L2variants and dietary wholegrain products [33], the gly-
cemic index, glycemic load [34] and polyunsaturated fatty
acids [35] when considering the risks of T2D and athero-
genic dyslipidemia. In the present study, we observed that
the T risk allele of the rs7903146 SNP was associated with
an even greater increase in T2D risk (OR = 2.61) in sub-
jects with a high dessert intake (i.e. mainly sugary foods).
This association might be related to the higher fasting
plasma glucose concentrations observed in these subjects.
Our present results are in line with Grau et al.'s report that
the TCF7L2 rs7903146 SNP makes individuals differentially
sensitive to the carbohydrate and fat components of the
diet [36]. Investigation of the mechanisms by which
TCF7L2 rs7903146-macronutrient interactions affect
the T2D risk might yield new insights into the molecu-
lar basis of diabetes and thus provide opportunities for
more targeted preventive and therapeutic interventions.
Our study presented some limitations. Firstly, there
were few subjects with T2D (n = 76) in the ISOR study,
which lowers the study’s statistical power and reduces
the ability to detect significant associations with the T2D
risk. Using a threshold of p ≤ 0.05, the ISOR study had a
statistical power of at least 80% to detect odds ratios
ranging between 1.60 and 1.95 for allele frequencies ran-
ging from 0.40 to 0.10 respectively. The effect size of
rs7903146 was large enough to enable us to detect a
significant association with T2D. In contrast, the number
of subjects without T2D (n = 644) was too low to enable
us to detect significant associations with fasting glycemic
traits (except when diet was taken into account). Sec-
ondly, dietary consumption was assessed using a weekly
food frequency questionnaire; portion sizes were not
taken into account, which prevented us from calculating
the quantities of food types consumed. We acknowledge
that our data on gene-diet interactions are preliminary
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access to other populations with a similar ethnic back-
ground, and were thus unable to replicate our findings.
Lastly, the cross-sectional nature of the ISOR study
enables associations to be identified but cannot provide
information on causality.
Conclusions
Even though Algerian populations have a heterogeneous
genetic background, our present results showed that the
TCF7L2 rs7903146 polymorphism modulates the T2D
risk. Furthermore, we found that a high dessert intake
increased the T2D risk even more in risk allele carriers.
Given that the diet in urban areas of Algeria is evolving
towards the greater consumption of sugary foods, it will
be important to take our findings into account (if repli-
cated in independent cohorts) in attempts to combat the
rising prevalence of T2D.
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